文献速递甲状腺疾病

消融前刺激性甲状腺球蛋白对不同分化型甲状腺癌儿童及青少年的预后价值

Prognostic Value of Pre-Ablation Stimulated Thyroglobulin in Children and Adolescents with Differentiated Thyroid Cancer.
PubMed 文献 · Thyroid · 2020-02-20

该回顾性研究纳入118例接受全甲状腺切除及放射性碘治疗的儿童及青少年分化型甲状腺癌患者,中位随访5.3年。多因素分析显示消融前刺激性甲状腺球蛋白(s-Tg)和M1是持续/复发疾病的独立预测因素;s-Tg≤17.8 ng/mL预测无病状态的阴性预测值为96.8%。将s-Tg整合入美国甲状腺协会儿童风险分层后,中危和高危患者中s-Tg≤17.8 ng/mL与持续/复发疾病概率降低相关。

要点

  • 消融前s-Tg和M1是儿童及青少年分化型甲状腺癌持续/复发疾病的独立预测因素。
  • 消融前s-Tg预测无病状态的最佳切点为17.8 ng/mL,阴性预测值96.8%。
  • 中危和高危患者中,s-Tg≤17.8 ng/mL与持续/复发疾病概率降低相关。

核心结论

  • 研究提示消融前s-Tg能够预测儿童及青少年甲状腺癌的临床结局。

研究设计与样本

  • 回顾性研究,纳入118例儿童及青少年分化型甲状腺癌患者的临床记录,均接受全甲状腺切除和放射性碘治疗。

主要发现

  • 中位年龄16岁,女性占79.7%;中位随访5.3年后,68例(57.6%)无病,50例(42.4%)存在持续/复发疾病。
  • 多因素分析显示消融前s-Tg和M1是持续/复发疾病的独立预测因素。
  • 受试者工作特征曲线分析显示,预测无病状态的最佳消融前s-Tg切点为17.8 ng/mL,阴性预测值为96.8%。
  • 将消融前s-Tg整合入美国甲状腺协会儿童风险分层后,中危患者中s-Tg≤17.8 ng/mL者持续/复发疾病概率从22.6%降至2.6%,高危患者中从64.4%降至5.6%。

关键数值与推荐

  • 消融前s-Tg预测无病状态的最佳切点为17.8 ng/mL,阴性预测值96.8%。
  • 中危患者中,s-Tg≤17.8 ng/mL者持续/复发疾病概率为2.6%,s-Tg>17.8 ng/mL者为22.6%。
  • 高危患者中,s-Tg≤17.8 ng/mL者持续/复发疾病概率为5.6%,s-Tg>17.8 ng/mL者为64.4%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose: To systemically investigate the prognostic value of pre-ablation stimulated thyroglobulin (s-Tg) in children and adolescents with differentiated thyroid cancer. Methods: Clinical records from 118 children and adolescents were retrospectively reviewed. Results: The median age was 16 years, and the majority were female (79.7%). All children and adolescents underwent total thyroidectomy and received radioactive iodine therapy. After a median follow-up of 5.3 years, 68 (57.6%) patients were disease free, while 50 patients (42.4%) had persistent/recurrent disease. In multivariate analysis, pre-ablation s-Tg and M1 were the independent predictive factors for persistent/recurrent disease. According to the receiver operating curve analysis, the best pre-ablation s-Tg cutoff to predict disease-free status was 17.8 ng/mL with a negative predictive value of 96.8%. Integration of pre-ablation s-Tg into American Thyroid Association pediatric risk categories indicated that the presence of pre-ablation s-Tg ≤17.8 ng/mL was associated with a decreased chance of having persistent/recurrent disease in intermediate- and high-risk patients (22.6% to 2.6% in intermediate-risk patients, and 64.4% to 5.6% in high-risk patients). Conclusions: Our findings suggest that pre-ablation s-Tg has the capability of predicting the clinical outcomes in children and adolescents with thyroid cancer.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Liu L, Zhang X, Tian T, et al. Prognostic Value of Pre-Ablation Stimulated Thyroglobulin in Children and Adolescents with Differentiated Thyroid Cancer. Thyroid. 2020. PMID: 31964278. doi:10.1089/thy.2019.0585

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。